BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 27884920)

  • 1. Systematic review of bariatric surgery liver biopsies clarifies the natural history of liver disease in patients with severe obesity.
    Bedossa P; Tordjman J; Aron-Wisnewsky J; Poitou C; Oppert JM; Torcivia A; Bouillot JL; Paradis V; Ratziu V; Clément K
    Gut; 2017 Sep; 66(9):1688-1696. PubMed ID: 27884920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
    Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
    World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit-risk of intraoperative liver biopsy during bariatric surgery: review and perspectives.
    Barbois S; Arvieux C; Leroy V; Reche F; Stürm N; Borel AL
    Surg Obes Relat Dis; 2017 Oct; 13(10):1780-1786. PubMed ID: 28935200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients.
    D'Incao RB; Tovo CV; Mattevi VS; Borges DO; Ulbrich JM; Coral GP; Ramos MJ; Meinhardt NG
    Obes Surg; 2017 Aug; 27(8):2151-2158. PubMed ID: 28281237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study.
    Ooi GJ; Burton PR; Bayliss J; Raajendiran A; Earnest A; Laurie C; Kemp WW; McLean CA; Roberts SK; Watt MJ; Brown WA
    Obes Surg; 2019 Jan; 29(1):99-108. PubMed ID: 30229460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
    Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
    Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.
    Seki Y; Kakizaki S; Horiguchi N; Hashizume H; Tojima H; Yamazaki Y; Sato K; Kusano M; Yamada M; Kasama K
    J Gastroenterol; 2016 Mar; 51(3):281-9. PubMed ID: 26314837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
    Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
    Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body mass index and the visceral adipose tissue expression of IL-6 and TNF-alpha are associated with the morphological severity of non-alcoholic fatty liver disease in individuals with class III obesity.
    Jorge ASB; Andrade JMO; Paraíso AF; Jorge GCB; Silveira CM; de Souza LR; Santos EP; Guimaraes ALS; Santos SHS; De-Paula AMB
    Obes Res Clin Pract; 2018; 12(Suppl 2):1-8. PubMed ID: 27083404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive Evaluation of NAFLD with Indocyanine Green Clearance Test: a Preliminary Study in Morbidly Obese Patients Undergoing Bariatric Surgery.
    Danin PE; Anty R; Patouraux S; Raucoules-Aimé M; Gugenheim J; Tran A; Gual P; Iannelli A
    Obes Surg; 2018 Mar; 28(3):735-742. PubMed ID: 28875438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of bariatric surgery in patients with advanced fibrosis.
    Singh T; Kochhar GS; Goh GB; Schauer P; Brethauer S; Kroh M; Aminian A; Lopez R; Dasarathy S; McCullough AJ
    Int J Obes (Lond); 2017 Mar; 41(3):443-449. PubMed ID: 27881858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual Liver Score to Stratify Non-Alcoholic Steatohepatitis Risk and Determine Selective Intraoperative Liver Biopsy in Obesity.
    Ooi GJ; Burton PR; Earnest A; Laurie C; Kemp WW; Nottle PD; McLean CA; Roberts SK; Brown WA
    Obes Surg; 2018 Feb; 28(2):427-436. PubMed ID: 28776153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of NAFLD and bariatric surgery on hepatic and adipose tissue mitochondrial biogenesis and respiration.
    Pedersen JS; Rygg MO; Chrøis K; Sustarsic EG; Gerhart-Hines Z; Wever Albrechtsen NJ; Serizawa RR; Kristiansen VB; Basse AL; Boilesen AEB; Olsen BH; Hansen T; Gluud LL; Madsbad S; Larsen S; Bendtsen F; Dela F
    Nat Commun; 2022 May; 13(1):2931. PubMed ID: 35614135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.
    Kazankov K; Tordjman J; Møller HJ; Vilstrup H; Poitou C; Bedossa P; Bouillot JL; Clement K; Grønbaek H
    J Gastroenterol Hepatol; 2015 Aug; 30(8):1293-300. PubMed ID: 25772748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and prevalence of liver disease in review of 2557 routine liver biopsies performed during bariatric surgery.
    Udelsman BV; Corey KE; Lindvall C; Gee DW; Meireles OR; Hutter MM; Chang DC; Witkowski ER
    Surg Obes Relat Dis; 2019 Jun; 15(6):843-849. PubMed ID: 31014948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative Liver Biopsy During Adolescent Bariatric Surgery: Is It Really Necessary?
    Jones RE; Yeh AM; Kambham N; El Haija MA; Pratt J; Bruzoni M
    Obes Surg; 2020 Jan; 30(1):69-76. PubMed ID: 31446562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Liver Disease on Perioperative Outcome After Bariatric Surgery in a Northern German Cohort.
    Wolter S; Duprée A; Coelius C; El Gammal A; Kluwe J; Sauer N; Mann O
    Obes Surg; 2017 Jan; 27(1):90-95. PubMed ID: 27272667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HAALT Non-invasive Scoring System for NAFLD in Obesity.
    Sheth H; Bagasrawala S; Shah M; Ansari R; Olithselvan A; Lakdawala M
    Obes Surg; 2019 Aug; 29(8):2562-2570. PubMed ID: 31016455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
    Helling TS; Helzberg JH; Nachnani JS; Gurram K
    Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Utility of Liver Biopsy During Bariatric Surgery in the New Zealand Setting.
    Collins H; Beban G; Windsor J; Ram R; Orr D; Evennett N; Loveday B
    Obes Surg; 2020 Jan; 30(1):313-318. PubMed ID: 31482482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.